Dermata Therapeutics, Inc. (DRMA)
NASDAQ·Healthcare·Biotechnology
$1.13
-2.17%
Mkt Cap $903.06K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+433.3%
Consensus $6.00 vs current $1.13
NASDAQ·Healthcare·Biotechnology
$1.13
-2.17%
Mkt Cap $903.06K
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
+433.3%
Consensus $6.00 vs current $1.13